[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
Dementia with Lewy Bodies (DLB) accounts for approximately 20 % of all autopsy-confirmed dementias in the elderly. Presumably, DLB is underdiagnosed in patients without or with only mild Parkinsonian symptoms in the daily routine of memory clinics. This motivated the Austrian Alzheimer Society and the Austrian Parkinson Society to inform about core features, suggestive features and supportive clinical findings of DLB and to provide information on diagnostic possibilities leading to better differential diagnosis. We also guide in the management of DLB as pharmacological treatment can pose difficult dilemmas for the treating clinician.
Ransmayr
Gerhard
G
Neurologische Universitätsklinik Graz, Medizinische Universität Graz. reinhold.schmidt@meduni-graz.at
Katzenschlager
Regina
R
Dal-Bianco
Peter
P
Wenning
Gregor
G
Bancher
Christian
C
Jellinger
Kurt
K
Schmidt
Reinhold
R
Poewe
Werner
W
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001317:Austria; D001921:Brain / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D020961:Lewy Body Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D009483:Neuropsychological Tests
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D007980:Levodopa